3rd World Congress on

Addiction Medicine, Behavioral Health and Psychiatry

THEME: "Innovations in Addiction Medicine, Behavioral Health, and Psychiatry Studies"

img2 23-24 Mar 2026
img2 London, UK
Tammy Davis

Tammy Davis

Aromagenomics, United States

Title: Myrrh Essential Oil and the Endogenous Opioid System: Evidence-Based Neuroaromatherapy for Addiction Treatment and Trauma Recovery


Biography

Tammy L. Davis is a Clinical Neuroaromatherapist and founder of Aromagenomics, specializing in evidence-based essential oil interventions for neurological conditions and addiction recovery. With extensive training in neuropharmacology and clinical aromatherapy, she bridges traditional aromatic medicine with contemporary neuroscience. Her work focuses on the endogenous opioid system's role in social bonding and addiction pathophysiology, developing community-based protocols that integrate neuroaromatherapy with conventional treatment approaches. She has trained healthcare professionals internationally on implementing scientifically grounded aromatherapy interventions and advocates for integrative approaches addressing both neurobiological dysregulation and social disconnection in recovery.

Abstract